98%
921
2 minutes
20
The present prospective cohort study evaluated the prevalence of FSH-R receptor Asn680Ser and Ala307Thr among infertile Indian women and the correlation of these polymorphisms with ART outcomes. Total 804 infertile and 209 fertile controls were enrolled for FSH-R analysis. Correlation of different genotypes with ovarian reserve markers, IVF parameters, and cumulative live birth rates (CLBR) was done among women undergoing IVF. In fertile controls, at 680 position GG (Ser/Ser) was the most common genotype; but among infertile women, all the genotypes were equally distributed. There was no significant difference in ovarian response parameters, oocyte yield, and CLBR among the three genotype groups. Empty follicle syndrome (EFS) was highest in women with AA or AG type at both positions. On categorisation of unexpected poor responders according to POSEIDON stratification; GG genotype at both positions had the lowest risk ratio of low-oocyte yield in ART cycles, but these differences were not statistically significant. This is the largest study from Indian ethnicity showing GG (Ser/Ser) genotype is most common among fertile women. The effect of FSH-R genotypes is very marginal on IVF parameters and is not reflected in CLBR. More prospective data may be required on the correlation of these genotypes with genuine EFS, thus stratifying the next cycles with self or donor oocytes. Routine genetic testing of FSH-R polymorphism should not be done except in a research setting. As both 680 and 307 positions are in linkage disequilibrium, only 680 position analysis may be done in a research setting.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/s10038-024-01251-8 | DOI Listing |
Front Endocrinol (Lausanne)
July 2025
Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.
Background: Letrozole is a first-line treatment for anovulatory infertility in women with polycystic ovary syndrome (PCOS). Despite its widespread use, a significant proportion of patients exhibit non-responsive cycles, limiting treatment efficacy. Identifying predictive markers for ovarian response could enhance the efficiency and cost-effectiveness of ovulation induction.
View Article and Find Full Text PDFFront Endocrinol (Lausanne)
May 2025
Department of Translational Medicine, Lund University, Malmö, Sweden.
Objective: This study aimed to compare cumulative [fresh and frozen embryo transfers from one ovarian stimulation (OS) cycle] pregnancy and live birth rates in women for whom the choice between recombinant FSH (rFSH) and urinary FSH (uFSH) for OS was linked to FSH receptor (FSHR) N680S genotype and compared these to non-genotyped controls.
Methods: To define the optimal combination of FSH type and FSHR genotype, 475 women were allocated to either the rFSH group or to the uFSH group for OS. The number of aspirated oocytes, cumulative pregnancy rates, and live birth rates in the first OS cycle were determined.
Georgian Med News
February 2025
9Department of Medical Laboratory Sciences, College of Health Sciences, Gulf Medical University.
Polycystic Ovary Syndrome (PCOS) or the polycystic ovarian syndrome is one of the most prevalent endocrinal disorders in women of the reproductive age and is defined with characteristic features such as oligoovulation and hyperandrogenism. The study aims to investigate genetic mutation in the follicle-stimulating hormone receptor (FSHR) in PCOS Sudanese women and its correlation with hormonal profiles and clinical patterns of this syndrome. This is a cross-section study recruited 80 subjects; forty women diagnosed with PCOS by Rotterdam criteria and forty healthy control subjects.
View Article and Find Full Text PDFTaiwan J Obstet Gynecol
November 2024
Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, China. Electronic address:
Reprod Sci
November 2024
Dexeus Fertility, Dexeus University Hospital, 08028, Barcelona, Spain.
To analyze whether combinations of polymorphisms within FSHR gene influence ovarian response (OR) to stimulation. A multicenter prospective cohort study was conducted from 11/2016-06/2019 in Europe and Asia including predicted normo-responders under 38y. Patients underwent ovarian stimulation using fixed-dose 150 IU rFSH in a GnRH antagonist protocol.
View Article and Find Full Text PDF